drug discovery


phase 1

phase 2

al01211 for fabry disease

al01211 for kidney disease
(kidney fibrosis, polycystic kidney disease)

AL00804 for neuropathic diseases

undisclosed drug discovery program for kidney diseases

In addition to the above, we leverage the rich experience of our internal drug discovery team to discover and develop new drug assets for kidney diseases.
© Copyright AceLink Therapeutics. All rights reserved